Amanote Research
Register
Sign In
Genetic Polymorphisms in Cytotoxic T-Lymphocyte Antigen 4 and Cancer: The Dialectical Nature of Subtle Human Immune Dysregulation
Cancer Research
- United States
doi 10.1158/0008-5472.can-09-0176
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 28, 2009
Authors
T. Sun
Z. Hu
H. Shen
D. Lin
Publisher
American Association for Cancer Research (AACR)
Related search
Cytotoxic T-Lymphocyte Antigen 4 (Ctla-4) Gene Polymorphisms in Bronchial Asthma.
International Journal of Advanced Research
Association Between the Cytotoxic T-Lymphocyte Antigen-4 Polymorphisms and Breast Cancer Risk and Prognosis
Journal of Cancer Metastasis and Treatment
Cytotoxic T Lymphocyte Antigen 4 Polymorphism 49 (A>G) and Migraine
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Association Between the Cytotoxic T-Lymphocyte Antigen 4-318c/T Polymorphism and Malignant Tumor Risk
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Influence of Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Cytotoxic T Lymphocyte Associated Antigen 4 Expression Predicts Poor Prognosis in Luminal B HER2-negative Breast Cancer
Oncology Letters
Cancer Research
Oncology
The Cytotoxic T Lymphocyte Immune Synapse at a Glance
Journal of Cell Science
Cell Biology
Common Variants on Cytotoxic T Lymphocyte Antigen-4 Polymorphisms Contributes to Type 1 Diabetes Susceptibility: Evidence Based on 58 Studies
PLoS ONE
Multidisciplinary
A Matrix Metalloproteinase Inhibitor Enhances Anti-Cytotoxic T Lymphocyte Antigen-4 Antibody Immunotherapy in Breast Cancer by Reprogramming the Tumor Microenvironment
Oncology Reports
Medicine
Cancer Research
Oncology
